PRESS RELEASE published on 08/06/2025 at 23:00, 8 months 2 days ago Viemed Healthcare Announces Second Quarter 2025 Financial Results Viemed Healthcare, Inc. reports Q2 2025 financial results with net revenues reaching $63.1 million and net income increasing by 115.1% to $3.2 million. The company's operational highlights and updated full year guidance are discussed Financial Results Updated Guidance Net Revenues Q2 2025 Viemed Healthcare
PRESS RELEASE published on 08/06/2025 at 22:30, 8 months 2 days ago Telkom South Africa Successfully Modernizes its Legacy Business Support Systems with Amdocs’ Cloud-Native Customer Experience Suite Amdocs announces successful BSS transformation with Telkom South Africa enhancing customer experience and innovation for 25 million subscribers Innovation Amdocs Customer Experience Telkom South Africa BSS Transformation
PRESS RELEASE published on 08/06/2025 at 22:20, 8 months 2 days ago A1 Macedonia Selects Amdocs to Modernize its Monetization Platforms A1 Macedonia partners with Amdocs to modernize monetization platforms, enhancing operational efficiencies and customer experiences. Amdocs to deploy billing, charging, and product catalog solutions for converged and cloud-ready foundation Amdocs Customer Experience Monetization Modernization A1 Macedonia
PRESS RELEASE published on 08/06/2025 at 22:15, 8 months 2 days ago Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength Amrize delivers solid second quarter results showing strength in business and market positions. Launches ASPIRE program for synergies and accelerates margin expansion Financial Results Market Growth Amrize ASPIRE Program Investment-grade Balance Sheet
PRESS RELEASE published on 08/06/2025 at 22:15, 8 months 2 days ago Kingstone Stockholders Approve Company Proposals at 2025 Annual Meeting Kingstone Companies, Inc. announces updated board composition following annual stockholders meeting. Pranav Pasricha elected to the Board Insurance Kingstone Companies Inc. Annual Meeting Board Composition Pranav Pasricha
PRESS RELEASE published on 08/06/2025 at 22:12, 8 months 2 days ago Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth Zomedica Corp. reports record year-over-year revenue for 18th straight quarter, with 14% growth in Q2 2025 driven by Diagnostic and Consumable segments Financial Results Zomedica Corp. Record Revenue Veterinary Health Growth
PRESS RELEASE published on 08/06/2025 at 22:10, 8 months 2 days ago Consumer Cellular Expands Strategic Collaboration with Amdocs to Accelerate AI-Driven MVNE Capabilities Amdocs expands agreement with Consumer Cellular to enhance MVNE platform with AI & Data Platform, Customer Experience Insights, and amAIz Suite for improved onboarding, operations, and customer experiences Amdocs AI Customer Experiences Consumer Cellular MVNE Platform
PRESS RELEASE published on 08/06/2025 at 22:10, 8 months 2 days ago Gladstone Commercial Corporation Reports Results for the Second Quarter Ended June 30, 2025 Gladstone Commercial Corporation reports financial results for Q2 2025 including FFO and Core FFO financial measures. Visit the website for detailed information Financial Results Gladstone Commercial Corporation FFO Core FFO Q2 2025
PRESS RELEASE published on 08/06/2025 at 22:05, 8 months 2 days ago FRP Holdings, Inc. Reports Fiscal 2025 Second Quarter Results FRP Holdings, Inc. reports 72% decrease in Net Income for Q2 2025, along with increases in pro rata NOI for Multifamily and Mining segments. Company's focus on industrial business and new projects highlighted Growth Strategy Financial Results Real Estate Industrial Segment FRP Holdings
PRESS RELEASE published on 08/06/2025 at 22:05, 8 months 2 days ago Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update Protagonist Therapeutics reports NDA submission for icotrokinra for PsO treatment, Phase 2b trial for icotrokinra in UC, VERIFY trial data of rusfertide in PV, and financial results for Q2 2025 Financial Results Protagonist Therapeutics Psoriasis Icotrokinra Phase 3 VERIFY Trial
Published on 04/09/2026 at 19:15, 1 hour 27 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 42 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 6 hours 2 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 42 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 7 hours 12 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 18:45, 1 hour 57 minutes ago EUROPLASMA: Tirage de 200 obligations convertibles en actions nouvelles pour un montant nominal de 1M€
Published on 04/09/2026 at 18:15, 2 hours 27 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 20:00, 42 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 1er trimestre 2026
Published on 04/09/2026 at 18:35, 2 hours 7 minutes ago Mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 30 avril 2026
Published on 04/09/2026 at 18:35, 2 hours 7 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 17:45, 2 hours 57 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mars 2026